The unforeseen suspension of recruitment in many clinical trials has created a long‐term impact on clinical trials and directly on the patient's treatment in some of these trials which has created an eagerness to streamline the process into virtual trials.

Virtual trials are expected to develop into new and powerful means of collecting minimal amount of credible, replicable, and evaluable data needed to answer meaningful questions with the least time and better safety reviews.

Remotely-based principal investigator and virtual care team gather data from more patients constantly resulting in better physician oversight and ability without onsite visits. The technology underpinning virtual trials with notifications, reporting and scheduling functions makes the job simpler for researchers by removing tedious administrative duties.

Fierce competition for sites with added burden from late-phase studies makes virtual trials attractive. Gathering patient data at home helps guarantee patient retention and trial compliance.